Back to
Trexquant Investment LP
AXSM
Showing 6 of 19 quarters
Position history for
Trexquant Investment LP's holdings in AXSOME THERAPEUTICS INC.
Yes. Trexquant Investment holds 83,679 shares of AXSM (Axsome Therapeutics), worth $20.5M, as of its Q2 2026 13F filing. It increased the position from 5,935 shares in Q1 2026. Trexquant Investment has held AXSM since Q3 2025, across 4 quarterly 13F filings. AXSM is 0.1% of Trexquant Investment's reported 13F portfolio.
Current Value
$20.5M
Current Shares
83,679
Total Value Change
+$19.3M
Total Shares Change
+69,550
Quarter-by-Quarter History